C07D 409/14
Containing three or more hetero rings
Official title: containing three or more hetero rings
C07D409/14 (Containing three or more hetero rings) appears on 5,975 US grants and 7,564 published applications in this corpus.
Search patents in C07D- Granted patents
- 5,975
- Published applications
- 7,564
- Assignees
- 1,900
- Inventors
- 18,944
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 7 | 0 |
| 1977 | 6 | 0 |
| 1978 | 4 | 0 |
| 1979 | 2 | 0 |
| 1980 | 1 | 0 |
| 1981 | 2 | 0 |
| 1982 | 3 | 0 |
| 1983 | 4 | 0 |
| 1984 | 6 | 0 |
| 1985 | 14 | 0 |
| 1986 | 11 | 0 |
| 1987 | 26 | 0 |
| 1988 | 12 | 0 |
| 1989 | 24 | 0 |
| 1990 | 29 | 0 |
| 1991 | 45 | 0 |
| 1992 | 46 | 0 |
| 1993 | 59 | 0 |
| 1994 | 43 | 0 |
| 1995 | 52 | 0 |
| 1996 | 43 | 0 |
| 1997 | 54 | 0 |
| 1998 | 69 | 0 |
| 1999 | 69 | 0 |
| 2000 | 103 | 0 |
| 2001 | 99 | 17 |
| 2002 | 123 | 118 |
| 2003 | 124 | 237 |
| 2004 | 111 | 338 |
| 2005 | 126 | 290 |
| 2006 | 158 | 272 |
| 2007 | 152 | 308 |
| 2008 | 164 | 268 |
| 2009 | 196 | 350 |
| 2010 | 228 | 341 |
| 2011 | 257 | 312 |
| 2012 | 245 | 290 |
| 2013 | 290 | 324 |
| 2014 | 314 | 338 |
| 2015 | 308 | 362 |
| 2016 | 252 | 331 |
| 2017 | 290 | 312 |
| 2018 | 237 | 285 |
| 2019 | 227 | 298 |
| 2020 | 238 | 321 |
| 2021 | 189 | 276 |
| 2022 | 184 | 304 |
| 2023 | 188 | 415 |
| 2024 | 188 | 341 |
| 2025 | 215 | 291 |
| 2026 | 138 | 225 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Diaminopyrimidine carboxamide inhibitors of HPK16 Oct 2026US 12,753,163 B2Merck Sharp & Dohme Corp.
- 1,5-disubstituted 1,2,3-triazoles are inhibitors of RAC/CDC42 GTPases6 Oct 2026US 12,753,183 B2University of Puerto Rico
- Organic light-emitting device and apparatus including the same6 Oct 2026US 12,757,632 B2Samsung Display Co., Ltd.
- Organic molecules for use in light-emitting devices29 Sep 2026US 12,747,210 B2Samsung Display Co., Ltd.
- Compounds, compositions, and methods29 Sep 2026US 12,747,232 B2Denali Therapeutics Inc.
- Estrogen-receptor modulator and use thereof8 Oct 2026US 2026/0308139 A1Jiangsu Vcare PharmaTech Co., Ltd.
- 5-ht2a receptor inverse agonist, and preparation method therefor and use thereof8 Oct 2026US 2026/0308142 A1Luye Innomind Pharma Shijiazhuang Co., Ltd.
- Targeting rnas associated with tauopathies with small molecules8 Oct 2026US 2026/0308158 A1University of Florida Research Foundation, Inc.
- Supported olefin polymerization catalysts comprising substituted 2-hydroxythiophene compounds8 Oct 2026US 2026/0308284 A1Dow Global Technologies LLC
- Neuroactive androgen receptor modulators and use thereof1 Oct 2026US 2026/0294908 A1ENDOCHEM PHARMACEUTICALS (BEIJING) CO., LTD. Beijing
Most cited
By later US patents
- Electron-conducting molecular preparations291US 5,556,524 AValtion Teknillinen Tutkimuskeskus · 1996
- Intermediates useful for making 2,4-pyrimidinediamine compounds192US 7,060,827 B2Rigel Pharmaceuticals, Inc. · 2006
- Methods for generating high titer helper-free preparations of released recombinant AAV vectors183US 6,566,118 B1Targeted Genetics Corporation · 2003
- 2,4-pyrimidinediamine compounds and their uses176US 7,557,210 B2Rigel Pharmaceuticals, Inc. · 2009
- Kinase inhibitors175US 6,831,175 B2Abbott Laboratories · 2004